We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Arrow Pharma Pty Ltd
I, Leanne McCauley, Delegate of the Secretary to the Department of Health, on receipt of an application from Arrow Pharma Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 the restricted representations specified in column 2 of the table below for use in advertisements specified in column 3 about the therapeutic goods specified in column 4:
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| Item | Restricted representation | Advertisement | Therapeutic goods |
| 1 | "For the prevention and treatment of medically diagnosed iron deficiency anaemia" | an advertisement about the therapeutic goods specified in column 4 including, but not limited to, an advertisement that is:
| FERROGEN ferrous sulphate 325mg tablets bottle pack (AUST R 329944) |
| 2 | "For the prevention and treatment of medically diagnosed iron deficiency" | an advertisement about the therapeutic goods specified in column 4 including, but not limited to, an advertisement that is:
| FERROGEN IRON + VITAMIN C modified release tablets (AUST R 329167) |
| 3 | "For the prevention and treatment of iron deficiency anaemia" | an advertisement about the therapeutic goods specified in column 4 that is:
| FERROGEN ferrous sulphate 325mg tablets bottle pack (AUST R 329944) |
| 4 | "For the prevention and treatment of iron deficiency, with vitamin C" | an advertisement about the therapeutic goods specified in column 4 that is:
| FERROGEN IRON + VITAMIN C modified release tablets (AUST R 329167) |
Dated this day 3 June 2020
Signed electronically
Leanne McCauley
Delegate of the Secretary to the Department of Health
Advertising Compliance Unit
Regulatory Compliance Branch